See also this year's filing and all EDGAR filings for this company.
PDF Report 0001438533_2026_Travere_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001438533, Travere Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 437,565,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 113,868,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,022,000 |
| 3 | remainder_Assets | 49,736,000 |
| 4 | LiabilitiesCurrent | 159,904,000 |
| 5 | LiabilitiesNoncurrent | 18,735,000 |
| 6 | remainder_Liabilities | 311,724,000 |
| 7 | CostOfGoodsAndServicesSold | 9,658,743 |
| 8 | SellingGeneralAndAdministrativeExpense | 435,620,432 |
| 9 | ResearchAndDevelopmentExpense | 202,091,703 |
| 10 | remainder_Expenses | 26,202,555 |
| 11 | remainder_Revenues | 1,772,331,590 |
| 12 | remainder_NetIncome | 25,396,095 |
| 13 | remainder_ComprehensiveNetIncome | 89,700 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 605,191,000 |
| 1 | Liabilities | 490,363,000 |
| 2 | Expenses | 673,573,433 |
| 3 | Revenues | 1,772,331,590 |
| 4 | StockholdersEquity | 114,828,000 |
| 5 | NetIncome | 1,124,154,252 |
| 6 | ComprehensiveNetIncome | 1,124,199,102 |
| 7 | BaseVar | 1,783,472,409 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.51 |
| 9 | EconomicCapitalRatio | 3.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
